Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Decitabine
The First People's Hospital of Lianyungang
Thrombocytopenia
1 trial -
Decitabine plus HAAG regimen
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Decitabine, Homoharringtonine, Aclarubicin, Cytarabine and G-CSF
Hospital Authority, Hong Kong
Acute Myeloid Leukemia
1 trial -
Depigoid Grass-Mix (1000 DPP/ml), Conjunctival Provocation Test Grass-Mix LETI 30 HEP/ml, The placebo to be used in the clinical trial is the solvent used in the investigational medicinal products’ (IMPs) formulation. The resulting product is a suspension., Depigoid FORTE Grass-Mix (3000 DPP/ml)
Lacuna Pharma Pty Ltd
Allergic rhinoconjunctivitis with or without controlled asthma
1 trial -
Dexamethasone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Respiratory Distress Syndrome (ARDS)
1 trial -
Dexamethasone Tablets BP 2.0mg, Fortecortin® 2 mg Tabletten, Lenalidomide Accord 15 mg hard capsules, CARVYKTI 3.2 × 10^6 – 1.0 × 10^8 cells dispersion for infusion, Lenalidomide Mylan 5 mg hard capsules, Lenalidomide Mylan 20 mg hard capsules, VELCADE 3.5 mg powder for solution for injection, Lenalidomide Mylan 20 mg hard capsules, Lenalidomide Accord 10 mg hard capsules, Lenalidomide Accord 2.5 mg hard capsules, FLUDARABINE , Lenalidomide Mylan 15 mg hard capsules, Lenalidomide Accord 10 mg hard capsules
Janssen-Cilag International N.V.
Multiple Myeloma
1 trial -
Dexamethasone sodium phosphate
Quince Therapeutics
Ataxia Telangiectasia
2 trials -
Dexamethasone sodium phosphate for encapsulation into autoerythrocytes
Quince Therapeutics
Ataxia Telangiectasia (A-T)
1 trial -
Dexmedetomidine Hcl 100 Mcg/mL Inj
Hospital Authority, Hong Kong
Congenital Heart Disease in Children
1 trial -
Diacomit 250 mg hard capsules, Matched Placebo will consist in caspules similar to the 250 and 500 mg capsules of stiripentol but with no active ingredient, Diacomit 500 mg hard capsules
Biocodex
Primary Hyperoxaluria (PH) of all subtypes (PH1, PH2 and PH3)
1 trial -
Dienogest
Hospital Authority, Hong Kong
Endometriosis
1 trial -
Diflucan 200mg Hard Capsules, PLACEBO to Posaconazol hexal, Posaconazol HEXAL 100 mg, NOXAFIL® (posaconazole) Injection, Placebo to bactrim, diflucan 200 mg - microcrystalline cellulose capsules, DIFLUCAN INJECTION, REZZAYO 200 mg powder for concentrate for solution for infusion, Saline solution, REZZAYO 200 mg powder for concentrate for solution for infusion, Bactrim Tablets, NOXAFIL® (posaconazole) Delayed-Release Tablets
Mundipharma Pty Limited
Invasive Fungal Diseases in Adults undergoing Allogeneic Blood and Marrow Transplantation (BMT)
1 trial -
Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Whooping Cough
1 trial -
Dipyridamole 50mg tid
The First People's Hospital of Lianyungang
Restless Leg Syndrome Due to Uraemia
1 trial -
Docetaxel+lobaplatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lobaplatin and Gemcitabine in Combination, Second-line Treatments on Advanced Osteosarcoma
1 trial -
Docetaxel, cisplatin and fluorouracil
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
Double encapsulated oral transplant of fecal microbiota, Enema transplant of fecal microbiota, Placebo double encapsulated oral transplant of fecal microbiota, Placebo coloscopic transplant of Fecal microbiota
Pari Pharma GmbH
Primary Sclerosing Cholangitis
1 trial -
Double encapsulated oral transplant of fecal microbiota, Placebo double encapsulated oral transplant of fecal microbiota
Pari Pharma GmbH
Severe Irritable Bowel Syndrome (IBS)
1 trial -
Dovato 50 mg/300 mg film-coated tablets, Dovato 50 mg/300 mg film-coated tablets, REKAMBYS 900 mg prolonged-release suspension for injection, Vocabria 400 mg prolonged-release suspension for injection, Vocabria 600 mg prolonged-release suspension for injection
ViiV Healthcare Pty Ltd
HIV-1 infection
1 trial -
Doxycycline
Hospital Authority, Hong Kong
Tuberculosis
1 trial -
Dupilumab SAR231893
Regeneron UK Limited
Chronic Spontaneous Urticaria
1 trial -
Dysport Placebo Solution for injection, Botulinum Toxin Type A 500 units Powder for solution for injection, Botulinum Toxin Type A 300 units Powder for solution for injection
Ipsen
Chronic migraine
1 trial -
Dysport Placebo Solution for injection, Botulinum Toxin Type A 300 units Powder for solution for injection, Botulinum Toxin Type A 500 units Powder for solution for injection
Ipsen
Episodic Migraine
1 trial -
EADM
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Carcinoma, Hepatocellular
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources